2023, Number 4
<< Back Next >>
Ortho-tips 2023; 19 (4)
Differences between the surgical techniques used on the median adductor in patients 18 to 36 months of age with developmental dysplasia of the hip
Ledezma RRN, Gómez CJ, Fuentes FS, Galván LR, Cantero CA
Language: Spanish
References: 21
Page: 214-219
PDF size: 174.26 Kb.
ABSTRACT
Introduction: developmental dysplasia of the hip presents catastrophic complications if not treated promptly. The goal of treatment is to obtain a reduced and concentric hip. An 8-20% redislocation is reported in hips treated for the first time, failure in the surgical technique when trying to obtain a concentric and stable head is one of the main causes.
Objective: to define if there is a difference between the surgical procedures on the median adductor muscle that influence the recurrence of hip dislocation in patients older than 18 months.
Material and methods: all the consecutive patients between 18 and 36 months with a diagnosis of developmental dysplasia of the hip who underwent surgery for the first time from January 2019 to August 2022 at the Shriners Hospital for Children in Mexico were included. It was grouped into three groups depending on the surgical technique performed on the median adductor. Group 1: without median adductor myotomy, group 2: percutaneous myotomy and group 3: open myotomy. All the information was taken from the hospital's clinical records.
Results: a total of 135 operated hips were obtained. There is evidence of a predominance in the female gender with 88% and the left hip (58.5%). Within the statistical analysis, an increased risk of redislocation was found in percutaneous versus open myotomies.
Conclusion: there is an increased risk of hip redislocation with patients treated with percutaneous median adductor myotomy versus open median adductor myotomy.
REFERENCES
Wenger DR. The Pediatric and adolescent hip: essentials and evidence. J Pediatr Orthop. 2020; 40 (7): e667. doi: 10.1097/BPO.0000000000001448.
Homer CJ, Baltz RD, Hickson GB, et al. Clinical practice guideline: early detection of developmental dysplasia of the hip. Committee on Quality Improvement, Subcommittee on Developmental Dysplasia of the Hip. American Academy of Pediatrics. Pediatrics. 2000; 105 (4 Pt 1): 896-905. doi: 10.1542/peds.105.4.896.
Kotlarsky P, Haber R, Bialik V, Eidelman M. Developmental dysplasia of the hip: what has changed in the last 20 years? World J Orthop. 2015; 6 (11): 886-901. doi: 10.5312/wjo.v6.i11.886.
Harper P, Joseph BM, Clarke NMP, et al. Even experts can be fooled: reliability of clinical examination for diagnosing hip dislocations in newborns. J Pediatr Orthop. 2020; 40 (8): 408-412. doi: 10.1097/BPO.0000000000001602.
Alshryda S, Wright J. Classification of hip joint dysplasia by means of sonography. Class Pap Orthop. 2013; 559-561. doi: 10.1007/978-1-4471-5451-8_147.
Graf R. Fundamentals of sonographic diagnosis of infant hip dysplasia. J Pediatr Orthop. 1984; 4 (6): 735-740. doi: 10.1097/01241398-198411000-00015.
Peled E, Bialik V, Katzman A, et al. Treatment of Graf's ultrasound class III and IV hips using Pavlik's method. Clin Orthop Relat Res. 2008; 466 (4): 825-829. doi: 10.1007/s11999-008-0119-5.
Tonnis D. Normal values of the hip joint for the evaluation of X-rays in children and adults. Clin Orthop Relat Res. 1976; (119): 39-47.
Frias-Austria R, García-Pinto G. La ley de detección de la DDC en niños, un logro del CMO. Acta Ortopédica Mexicana. 2016; 30 (6): 277-278.
Bicimolu A, Agus H, Omerolu H, Tümer Y. Six years of experience with a new surgical algorithm in developmental dysplasia of the hip in children under 18 months of age. J Pediatr Orthop. 2003; 23 (6): 693-698.
Mubarak SJ, Bialik V. Pavlik: the man and his method. J Pediatr Orthop. 2003; 23 (3): 342-346. doi: 10.1097/00004694-200305000-00012.
Swarup I, Ge Y, Scher D, et al. Open and closed reduction for developmental dysplasia of the hip in new york state: incidence of hip reduction and rates of subsequent surgery. JB JS Open Access. 2020; 5 (1): e0028. doi: 10.2106/JBJS.OA.19.00028.
Liu YH, Xu HW, Li YQ, et al. Effect of abduction on avascular necrosis of the femoral epiphysis in patients with late-detected developmental dysplasia of the hip treated by closed reduction: a MRI study of 59 hips. J Child Orthop. 2019; 13 (5): 438-444. doi: 10.1302/1863-2548.13.190045.
Castañeda PG, Moses MJ. Closed compared with open reduction in developmentally dislocated hips: a critical analysis review. JBJS Rev. 2019; 7 (10): 1-9. doi: 10.2106/JBJS.RVW.18.00179.
Tennant SJ, Eastwood DM, Calder P, Hashemi-Nejad A, Catterall A. A protocol for the use of closed reduction in children with developmental dysplasia of the hip incorporating open psoas and adductor releases and a short-leg cast mid-term outcomes in 113 hips. Bone Jt J. 2016; 98-B (11): 1548-1553. doi: 10.1302/0301-620X.98B11.36606.
Tennant SJ, Hashemi-Nejad A, Calder P, Eastwood DM. Bilateral developmental dysplasia of the hip: does closed reduction have a role in management? outcome of closed and open reduction in 92 hips. J Pediatr Orthop. 2019; 39 (4): E264-E271. doi: 10.1097/BPO.0000000000001297.
Elzohairy MM, Elhefnawy MM, Khairy HM. Revision of failed open reduction of developmental dysplasia of the hip. CiOS Clin Orthop Surg. 2020; 12 (4): 542-548. doi: 10.4055/cios19151.
El Hage S, Rachkidi R, Noun Z, Haidar R, Dagher F, Kharrat K, Ghanem I. Is percutaneous adductor tenotomy as effective and safe as the open procedure? J Pediatr Orthop. 2010; 30 (5): 485-488.
Karol LA. Surgical management of the lower extremity in ambulatory children with cerebral palsy. J Am Acad Orthop Surg. 2004; 12 (3): 196-203. doi: 10.5435/00124635-200405000-00008.
Ramani N, Patil M, Mahna M. Outcome of surgical management of developmental dysplasia of hip in children between 18 and 24 months. Indian J Orthop. 2014; 48 (5): 458-462. doi: 10.4103/0019-5413.139841.
Bhaskar A, Desai H, Jain G. Risk factors for early redislocation after primary treatment of developmental dysplasia of the hip: Is there a protective influence of the ossific nucleus? Indian J Orthop. 2016; 50 (5): 479-485. doi: 10.4103/0019-5413.189610.
EVIDENCE LEVEL
II-2 (cohorte).